Literature DB >> 22284345

T-category reflects the histopathologic characteristics of gallbladder cancer.

S Y Cho1, S S Han, S J Park, Y K Kim, S H Kim, S M Woo, W J Lee, T H Kim, E K Hong.   

Abstract

AIMS: Gallbladder (GB) cancer is a relatively uncommon gastrointestinal malignancy and is known to often result in unfavorable outcomes. Recent advances in aggressive surgical resection have improved the overall survival rate of patients with GB cancer. We aimed to evaluate the outcomes and prognostic factors of GB cancer following a surgical resection with curative intent.
METHODS: Between March 2001 and March 2009, 89 patients with GB cancer underwent surgical resection with curative intent at the National Cancer Center of Korea. We then conducted a retrospective analysis of clinicopathologic data.
RESULTS: Nineteen patients underwent simple cholecystectomy and 70 patients underwent extended cholecystectomy. Tumor-free resection margins were obtained in 84 cases. The 1-, 3- and 5-year disease-specific survival rates in the 89 patients were 85.8%, 68.0% and 64.1%, respectively. By multivariate analysis, only the T-category was significant (p < 0.001). The T-category showed a close correlation with all of the other histopathologic factors which were significant in univariate analysis.
CONCLUSION: The T-category of GB cancer represents not only the depth of the primary tumor but also the aggressiveness of its histopathologic nature.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284345     DOI: 10.1016/j.ejso.2012.01.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  1 in total

1.  Clinicopathological features of gallbladder papillary adenocarcinoma.

Authors:  Xueshuai Wan; Haohai Zhang; Cuimin Chen; Xiaobo Yang; Anqiang Wang; Chengpei Zhu; Lilan Fu; Ruoyu Miao; Lian He; Huayu Yang; Haitao Zhao; Xinting Sang
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.